Physician profile
Ali Abdullah Mithani
NPI 1952538555
$59,891.73
in general payments reported to CMS, 2019-2025
31 companies · $680 in 2025
The $680 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $19K · 2021: $12K · 2022: $4,464 · 2023: $2,036 · 2024: $731 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54,682.18 | 2019-2025 | Lifevest |
| Abbott Laboratories | $2,786.67 | 2019-2025 | Ensite, Gallant, Aveir |
| Novartis Pharmaceuticals Corporation | $293.59 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $245.71 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $224.05 | 2019-2025 | Watchman Access System, Apollo Esg System, Watchman Flx |
| Cardiva Medical, INC. | $219.31 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Itamar Medical INC | $202.78 | 2021-2022 | |
| Pfizer INC. | $191.67 | 2021-2025 | |
| Atricure, INC. | $143.18 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $131.31 | 2020-2025 | Eliquis |
| Novo Nordisk INC | $129.96 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $83.42 | 2022-2025 | Verquvo |
| Amarin Pharma, INC. | $76.53 | 2019-2020 | |
| Biosense Webster, INC. | $71.91 | 2023 | Carto 3 |
| Alnylam Pharmaceuticals INC. | $50.34 | 2022-2023 | Onpattro |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.16 | 2019-2024 | Jardiance |
| Amgen INC. | $37.33 | 2019 | |
| Impulse Dynamics (USA) INC. | $36.15 | 2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $30.90 | 2025 | Assure Wcd |
| Altathera Pharmaceuticals LLC | $24.98 | 2023 | Sotalol Hydrochloride |
| Recor Medical INC | $24.35 | 2025 | Paradise Ultrasound Renal Denervation System |
| Davol INC. | $23.74 | 2022 | |
| Esperion Therapeutics, INC. | $22.29 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $18.95 | 2019 | |
| Angiodynamics, INC. | $17.22 | 2022 | |
| Vifor Pharma, INC. | $16.78 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.60 | 2020 | |
| Baxter Healthcare | $14.07 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $14.02 | 2019 | |
| Philips North America LLC | $13.90 | 2025 | Ecc Solutions |
| Elutia, INC. | $10.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Mithani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.